Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo

• References

• 1 Barnett H.J.M.. 1978. Aspirin and sulfinpyrazone in threatened stroke. The results of the Canadian Collaborative Double Blind Trial. Breddin K., Dorndorf W., Loew D., Marx R.. Acetylsalicylic acid in cerebral ischemia and coronary heart disease. F.K. Schattauer Verlag; Stuttgart-New York: 93.
• 2 Boston Collaborative Drug Surveillance Group. 1974; Regular aspirin intake and acute myocardial infarction. Brit. med. J. 1: 440.
• 3 Coronary Drug Project Aspirin Study. 1976; Aspirin in coronary heart disease: The Coronary Drug Project Research Group. J. of chron. Dis. 29: 625.
• 4 Craven L. L.. 1956; Prevention of coronary and cerebral thrombosis. Miss. Valley Med. J. 78: 213.
• 5 Elwood P.C., Cochrane A.L., Burr m.L., Sweetnam P.M., Williams G., Welsby E., Hughes S.J., Renton R.. 1974; A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. Brit. med. J. 1: 403.
• 6 Fields W.S., Lemak N.A., Frankowski R.F., Hardy R.J.. 1977; Controlled trial of aspirin in cerebral ischemia. Stroked 8: 301.